PI3K blockade reverses primary resistance and adaptation to eribulin in PI3K-pathway activated breast cancer tumors

Subjects

Subjects :

Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.disease
Blockade
chemistry.chemical_compound
Breast cancer
chemistry
Internal medicine
medicine
business
PI3K/AKT/mTOR pathway
Eribulin

Details

ISSN :

09598049

Volume :

61

Database :

OpenAIRE

Journal :

European Journal of Cancer

Accession number :

edsair.doi...........a5ed6b737158956e6e506a0d4edcb346

Full Text :

https://doi.org/10.1016/s0959-8049(16)61436-3